Medical Freezer VIP and PU Foaming in China

Illustration notice. Process illustrations are not verified photographs of this installation.

Project reference basis. Figures and configuration details are reported in the supplied project brief. They are reference values for the stated application, rather than verified acceptance results or a guarantee for another installation. Confirm the source records, material, tooling, operating schedule and test method when assessing a comparable project.

Project brief for review. The supplied document describes this configuration and reports the outcomes below. Original acceptance records, test reports and media are not attached to this import; attribution and outcomes require verification before publication.

The supplied brief describes the following project context.

A leading national cryogenic medical equipment technology enterprise in Anhui deployed Haifeng’s specialized VIP composite polyurethane foaming system. The project was commissioned to manufacture high-reliability insulation envelopes for 500 L to 800 L ultra-low temperature (-86°C) biological vaccine and specimen freezers.

Prior to this deployment, the manufacturer faced severe yield losses. High-velocity chemical streams from legacy mixing heads physically shifted and punctured fragile barrier foils on pre-installed vacuum insulation panels (VIP), causing a 6.5% panel failure rate. Furthermore, poor interfacial foam-to-VIP wet-out created micro-air chimneys; during power failure simulations, cabinet temperatures rose from -86°C past the stated -60°C test endpoint in just 1.5 hours, not meeting the submitted design target; biological storage requirements require separate validation.

Haifeng supplied an integrated micro-momentum foaming cell centered on the HF-ULT86-VIP system. Featuring diffused multi-port dispensing (< 8 m/s) and soft-vacuum cavity drawing (85 kPa), the equipment aimed to reduce VIP puncture defects, raising total wall thermal resistance by 40% and extending off-grid cold holding time to 4.2 hours.

Review point: Do not turn a -60°C trial endpoint into a universal vaccine/specimen safety threshold. The 0-defect claim is a submitted finite sample, not a guarantee. Cavity 85 kPa absolute and VIP internal vacuum are separate.

Reported equipment configuration from the supplied brief:

Haifeng engineered an ultra-gentle, high-pressure encapsulation cell designed for fragile composite assemblies. Pre-tested VIP panels are mounted into dedicated positioning grooves on the stainless steel cabinet liner using non-penetrating magnetic holders.

The cabinet core is positioned in a precision hydraulic clamping fixture, where a soft-vacuum skid evacuates the mold cavity to 85 kPa. High-functionality polyol and polymeric isocyanates are metered at 15.0 MPa via servo axial piston pumps under continuous Coriolis mass flow measurement.

Material discharges through a low-momentum multi-port diffuser head. Stream velocity is slowed from 30 m/s to 8 m/s, spreading gently into narrow 25 mm gaps behind the VIP panels without tearing the barrier films. Driven by soft-vacuum expansion, the fine closed-cell polyurethane foam locks tightly against the VIP surfaces, eliminating interfacial voids. After 15 minutes of in-mold curing at 45°C, the insulated cabinet undergoes 100% infrared thermal imaging to verify zero cold-bridge leakage.

Do not turn a -60°C trial endpoint into a universal vaccine/specimen safety threshold. The 0-defect claim is a submitted finite sample, not a guarantee. Cavity 85 kPa absolute and VIP internal vacuum are separate.